Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
FSGS/Nephrotic Syndrome Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 25 | 56 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
ITGA3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 99 | 101 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Centogene AG - the Rare Disease Company Germany | 157 | 151 |
|
Invitae Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (FSGS) Panel Invitae United States | 81 | 57 |
|
Invitae Epidermolysis Bullosa and Palmoplantar Keratoderma Panel Invitae United States | 95 | 45 |
|
Invitae Surfactant Metabolism Panel Invitae United States | 40 | 19 |
|
Invitae Neonatal Respiratory Distress Panel Invitae United States | 163 | 111 |
|
Nephrotic syndrome and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 27 | 32 |
|
Nephrotic syndrome and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 27 | 32 |
|
Nephrotic syndrome and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 27 | 32 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Progressive Renal Disease Panel Invitae United States | 310 | 195 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 527 | 338 |
|
Skin and Connective Tissue Disorders Panel PreventionGenetics, part of Exact Sciences United States | 125 | 69 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.